Jump to content
VA Disability Community via Hadit.com

  Click To Ask Your VA   Claims Questions | Click To Read Current Posts 
  
 Read Disability Claims Articles   View All Forums | Donate | Blogs | New Users |  Search  | Rules 

  • homepage-banner-2024-2.png

  • donate-be-a-hero.png

A Review Of The Neuropsychological Effects Of Commonly Used Prescription Medications.

Rate this topic


Guest allan

Recommended Posts

Arch Clin Neuropsychol. 1998 Apr;13(3):259-84.

A review of the neuropsychological effects of commonly used prescription medications.

Stein RA, Strickland TL.

HIV Mental Health Services, Harbor-UCLA Medical Center and Charles R. Drew University of Medicine and Science, Torrance, 90509, USA.

The practice of clinical neuropsychology has traditionally accorded limited attention to the impact of prescription medications on cognitive functioning. Though neuropsychologists see a wide array of patients with cerebropathologic and other organ system disease that are under pharmacotherapy, systematic attention to how these compounds potentially affect neuropsychological functioning has lagged. Psychomotor functioning, concentration, and memory are the most common cognitive domains negatively affected by such medications. In general sedative, psychomotor, and, to a lesser extent, attention/concentration effects covary and typically show tolerance with sustained drug administration. Memory effects are more resistant probably due to ongoing anticholinergic effects and the established link between the cholinergic system and memory functioning. This review covers the basic science and clinical literature addressing neuropsychological functioning both in healthy nonpatients and in patients treated with antidepressants, anxiolytics, stimulants, antihypertensives, antiepileptics and antihistamines. Critical to the understanding of the effects of these agents is the integration of multiple factors that modulate medication-induced neurocognitive effects, such as chronicity of treatment, tolerance, age, ethnicity, metabolic capacity, psychological, and neurological disorders in the patient, and the benefits of successful treatment of these disorders.

PMID: 14590642 [PubMed]

********************************************************************************

*********************************************************************************

******

Source: http://www.ncbi.nlm.nih.gov/entrez/query.f...t_uids=14590642

Edited by allan
Link to comment
Share on other sites

  • Replies 0
  • Created
  • Last Reply

Popular Days

Guest
This topic is now closed to further replies.
×
×
  • Create New...

Important Information

Guidelines and Terms of Use